{"title": "Revisi\u00f3n sistem\u00e1tica de art\u00edculos cient\u00edficos basados en Withania somn\u00edfera (Ashwagandha) como potencial terap\u00e9utico antiviral contra Covid-1", "author": "Monta\u00f1o Guevara; Marisol", "url": null, "hostname": null, "description": "Se llev\u00f3 a cabo una revisi\u00f3n sistem\u00e1tica de art\u00edculos basados en el estudio de Withania somn\u00edfera-WS como agente potencial antiviral de COVID-19. Se contempl\u00f3 una metodolog\u00eda cualitativa de tipo transversal y descriptivo, toda vez que la avalancha de literatura que se ha generado a causa de la propagaci\u00f3n del virus SARS-CoV-19, ha estado soportada en muchos casos en la pobreza ret\u00f3rica de medicina alternativa sin tener en cuenta aspectos toxicol\u00f3gicos. Luego, fue obtenido el listado de metadatos de WS y COVID-19 en dos bibliotecas digitales: Scopus y PubMed. Dicho volumen de datos fue procesado en herramienta de mapeo bibliom\u00e9tricas VOSwiever y analizado por metodolog\u00eda PRISMA. Se presentaron los an\u00e1lisis basados en evidencias, cuyos resultados demostraron que en fase in silico hay mayor n\u00famero de estudios que evaluaron los metabolitos de WS con acci\u00f3n interruptora entre el complejo ECA2 y la proteasa Mpro de COVID-19, siendo la Withaferin-A (Wi-A) el metabolito m\u00e1s ampliamente estudiado y el de mayor abundancia en la ra\u00edz de la planta, adem\u00e1s de la Withanona (Wi-N) y los Withan\u00f3sidos IV y V. No obstante, se concluy\u00f3 que la Wi-A fue considerada en 3 de los 13 art\u00edculos revisados como una alternativa segura en comparaci\u00f3n a otros f\u00e1rmacos sint\u00e9ticos. Finalmente, se concluy\u00f3 que NO son suficientes los estudios para concretar la viabilidad cl\u00ednica de la WS como agente potencial contra Mpro de COVID-19.", "sitename": "Corporaci\u00f3n Tecnol\u00f3gica de Bogot\u00e1", "date": "2022-07-22", "id": null, "license": "CC BY-NC-SA 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Revisi\u00f3n sistem\u00e1tica de art\u00edculos cient\u00edficos basados en Withania somn\u00edfera (Ashwagandha) como potencial terap\u00e9utico antiviral contra Covid-1\nTrabajo de grado - Pregrado\n2022\nCorporaci\u00f3n Tecnol\u00f3gica de Bogot\u00e1\nSe llev\u00f3 a cabo una revisi\u00f3n sistem\u00e1tica de art\u00edculos basados en el estudio de Withania somn\u00edfera-WS como agente potencial antiviral de COVID-19. Se contempl\u00f3 una metodolog\u00eda cualitativa de tipo transversal y descriptivo, toda vez que la avalancha de literatura que se ha generado a causa de la propagaci\u00f3n del virus SARS-CoV-19, ha estado soportada en muchos casos en la pobreza ret\u00f3rica de medicina alternativa sin tener en cuenta aspectos toxicol\u00f3gicos. Luego, fue obtenido el listado de metadatos de WS y COVID-19 en dos bibliotecas digitales: Scopus y PubMed. Dicho volumen de datos fue procesado en herramienta de mapeo bibliom\u00e9tricas VOSwiever y analizado por metodolog\u00eda PRISMA. Se presentaron los an\u00e1lisis basados en evidencias, cuyos resultados demostraron que en fase in silico hay mayor n\u00famero de estudios que evaluaron los metabolitos de WS con acci\u00f3n interruptora entre el complejo ECA2 y la proteasa Mpro de COVID-19, siendo la Withaferin-A (Wi-A) el metabolito m\u00e1s ampliamente estudiado y el de mayor abundancia en la ra\u00edz de la planta, adem\u00e1s de la Withanona (Wi-N) y los Withan\u00f3sidos IV y V. No obstante, se concluy\u00f3 que la Wi-A fue considerada en 3 de los 13 art\u00edculos revisados como una alternativa segura en comparaci\u00f3n a otros f\u00e1rmacos sint\u00e9ticos. Finalmente, se concluy\u00f3 que NO son suficientes los estudios para concretar la viabilidad cl\u00ednica de la WS como agente potencial contra Mpro de COVID-19.A systematic review of articles based on the study of Withania somn\u00edfera-WS as a potential antiviral agent of COVID-19 was carried out. A qualitative methodology of a cross-sectional and descriptive type was contemplated, since the avalanche of literature that has been generated due to the spread of the SARS-CoV-19 virus, has been supported in many cases in the rhetorical poverty of alternative medicine without taking into account toxicological aspects. Then, the list of WS and COVID-19 metadata was obtained in two digital libraries: Scopus and PubMed. This volume of data was processed in a VOSwiever bibliometric mapping tool and analyzed by PRISMA methodology. Evidence-based analyses were presented, the results of which showed that in the in silico phase there are a greater number of studies that evaluated the metabolites of WS with switching action between the ECA2 complex and the Mpro protease of COVID-19, with Withaferin-A (Wi-A) being the most widely studied metabolite and the one with the highest abundance in the root of the plant, in addition to the Withanona (Wi-N) and the Withanosides IV and V. However, it was concluded that Wi-A was considered in 3 of the 13 articles reviewed as a safe alternative compared to other synthetic drugs. Finally, it was concluded that studies are NOT enough to specify the clinical viability of WS as a potential agent against Mpro of COVID-19\nDescripci\u00f3n: 1. Proyecto final - Marisol Monta\u00f1o.pdf\nT\u00edtulo: 1. Proyecto final - Marisol Monta\u00f1o.pdf\nTama\u00f1o: 2.255Mb\n[PDF](/bitstream/handle/11158/4718/1.%20Proyecto%20final%20-%20Marisol%20Monta%c3%b1o.pdf?sequence=1&isAllowed=y)\nDescripci\u00f3n: 3. Formato BIB-01 (1) (1).xlsx\nT\u00edtulo: 3. Formato BIB-01 (1) (1).xlsx\nTama\u00f1o: 109.0Kb\nDescripci\u00f3n: 4. Formato BIB-02.pdf\nT\u00edtulo: 4. Formato BIB-02.pdf\nTama\u00f1o: 967.8Kb\n[PDF](/bitstream/handle/11158/4718/4.%20Formato%20BIB-02.pdf?sequence=3&isAllowed=n)\nT\u00edtulo: 1. Proyecto final - Marisol Monta\u00f1o.pdf\nTama\u00f1o: 2.255Mb\n[LEER EN FLIP](/flip/index.jsp?pdf=/bitstream/handle/11158/4718/1.%20Proyecto%20final%20-%20Marisol%20Monta%c3%b1o.pdf?sequence=1&isAllowed=y)\nDescripci\u00f3n: 3. Formato BIB-01 (1) (1).xlsx\nT\u00edtulo: 3. Formato BIB-01 (1) (1).xlsx\nTama\u00f1o: 109.0Kb\nDescripci\u00f3n: 4. Formato BIB-02.pdf\nT\u00edtulo: 4. Formato BIB-02.pdf\nTama\u00f1o: 967.8Kb", "language": null, "image": null, "pagetype": null, "links": ["#myCarousel", "#myCarousel", "https://repository.udca.edu.co:443/handle/11158/4718?locale-attribute=es", "https://repository.udca.edu.co:443/handle/11158/4718?locale-attribute=en", "#", "?locale-attribute=es", "?locale-attribute=en", "/login", "/", null, "/mydspace", "/register", "/browse?type=dateissued", "/browse?type=subject", "/search-filter?field=author", "/browse?type=type", "https://udca.edu.co/historia-mision-vision/", "https://udca.edu.co/normatividad-institucional/", "https://www.udca.edu.co/noticias/", "https://udca.edu.co/normatividad-institucional/", "/autoarchivo", "/", null, "/", "https://udca.janium.net/janium-bin/busqueda_rapida.pl?Id=20180820224443", "https://www.udca.edu.co/descubridor.html", "https://revistas.udca.edu.co/", "/statistics", "community-list", "search-filter?field=author", "browse?type=title", "browse?type=dateissued", "browse?type=subject", "#", "/", "/handle/11158/1", "/handle/11158/3505", "/handle/11158/3506", "#", "/", "/handle/11158/1", "/handle/11158/3505", "/handle/11158/3506", null, "/community-list", "/browse?type=dateissued", "/browse?type=author", "/browse?type=title", "/browse?type=subject", "/browse?type=type", null, "/handle/11158/3506/browse?type=dateissued", "/handle/11158/3506/browse?type=author", "/handle/11158/3506/browse?type=title", "/handle/11158/3506/browse?type=subject", "/handle/11158/3506/browse?type=type", "/login", "/register", "/handle/11158/4718/statistics", null, "/discover?field=author&filtertype=author&filter_relational_operator=equals&filter=Monta%C3%B1o Guevara, Marisol", null, "/discover?filtertype_1=orcidid&filter_relational_operator_1=equals&filter_1=0000-0001-8860-4041", "https://orcid.org/0000-0001-8860-4041", "/browse?value=Infecciones por Coronavirus&type=subject", "/browse?value=Infecciones por Coronavirus&type=subject", "/browse?value=Withania somnifera&type=subject", "/browse?value=Withania somnifera&type=subject", "/browse?value=Plantas medicinales&type=subject", "/browse?value=Plantas medicinales&type=subject", "https://repository.udca.edu.co/handle/11158/4718", "/handle/11158/3506", "/bitstream/handle/11158/4718/1.%20Proyecto%20final%20-%20Marisol%20Monta%c3%b1o.pdf?sequence=1&isAllowed=y", "/flip/index.jsp?pdf=/bitstream/handle/11158/4718/1.%20Proyecto%20final%20-%20Marisol%20Monta%c3%b1o.pdf?sequence=1&isAllowed=y", "/bitstream/handle/11158/4718/3.%20Formato%20BIB-01%20%281%29%20%281%29.xlsx?sequence=2&isAllowed=n", "/bitstream/handle/11158/4718/4.%20Formato%20BIB-02.pdf?sequence=3&isAllowed=n", "/handle/11158/4718?show=full", null, null, null, "/ris/index.jsp?handle=11158%2F4718&format=bib", "/ris/index.jsp?handle=11158%2F4718&format=ris", "/ris/index.jsp?handle=11158%2F4718&format=csv", "https://scholar.google.com/scholar?as_occt=title&as_q='Revisi%C3%B3n sistem%C3%A1tica de art%C3%ADculos cient%C3%ADficos basados en Withania somn%C3%ADfera (Ashwagandha) como potencial terap%C3%A9utico antiviral contra Covid-1'", "http://www.mendeley.com/import/?url=11158%2F4718", null, "https://creativecommons.org/licenses/by-nc-sa/4.0/", "https://scholar.google.com/scholar?hl=es&as_sdt=0%2C5&q=site%3Arepository.udca.edu.co&btnG=&oq=", "https://v2.sherpa.ac.uk/id/repository/4289", "https://repositorioslatinoamericanos.uchile.cl/handle/2250/3133333", "http://roar.eprints.org/16079/", "https://explore.openaire.eu/search/dataprovider?datasourceId=opendoar____::2b8f621e9244cea5007bac8f5d50e476", "https://www.base-search.net/Search/Results?q=dccoll:ftunivdca&refid=dcreces", "https://core.ac.uk/search?q=repositories.id:(15345)", "https://www.openarchives.org/Register/BrowseSites?viewRecord=https://repository.udca.edu.co/oai/request", "https://www.agrosavia.co/", "https://www.minagricultura.gov.co/paginas/default.aspx", "http://redcol.minciencias.gov.co/vufind/Search/Results?type=AllFields&lookfor=&filter%5B%5D=reponame_str%3A%22Repositorio+Institucional+UDCA%22&limit=20&sort=relevance", "https://www.lareferencia.info/vufind/Search/Results?lookfor=%2A%3A%2A&type=AllFields&filter%5B%5D=reponame_str%3A%22Repositorio%20Institucional%20UDCA%22", "#bottomCarousel", "#bottomCarousel", "https://www.instagram.com/SomosUDCA/", "https://twitter.com/SomosUDCA", "https://fb.me/somosudca", "https://www.youtube.com/user/udcauniversidad", "https://co.linkedin.com/school/universidadudca/", "https://play.google.com/store/apps/details?id=com.udca.universitasxxi.app&hl=es_CO", "https://apps.apple.com/es/app/udca/id1572243939", "https://www.tiktok.com/@somosudca", "https://virtual.udca.edu.co/", "https://www.udca.edu.co/normatividad-institucional/", "https://www.udca.edu.co/convocatorias-laborales/", "https://www.udca.edu.co/clinica-veterinaria/", "https://www.udca.edu.co/creditos-portal-web/", "https://www.udca.edu.co/politicas-terminos-condiciones/", "https://www.metabiblioteca.com", "https://www.metabiblioteca.com", "/htmlmap"]}